MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement. Under the agreement, Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
